People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular ...

Cross Keys Capital is a leading middle-market investment bank providing a full range of investment banking merger and acquisition advisory services to a variety of businesses nationally.

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

The ability to restore light responses in human retinas postmortem offers a novel model for studying retinal recovery and ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

A mechanism identified by a team from the Montreal Clinical Research Institute explains how the human brain reaches its ...

A research team led by Professor Hyunji Lee of the Department of Convergence Medicine at Korea University College of Medicine (co-first authors: PhD candidates Sanghun Kim, Ji Eun Kim, and Sungjin Ju; ...

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

Biotechnology firm Ocugen has bolstered its financial position, securing a pathway through a pivotal period for its lead gene therapy candidate. The company's shares, currently trading at 1.26 euros, ...

In February, when the sky often feels like a heavy wool blanket, there is a rare and fleeting magic that occurs: a sudden ...

A recent study has revealed that poor management of cardiovascular-kidney-metabolic (CKM) syndrome could increase the risk of age-related macular degeneration (AMD), a leading cause of vision loss ...